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T1a-LPM, T1a-MM or T1b-SM1, and T1b-SM2 tumors, 
respectively. We enrolled 211 patients with superficial 
esophageal squamous cell carcinoma. The overall accu-
racy of type B microvessels in estimating tumor invasion 
depth was 90.5 %. We propose that the newly developed 
JES magnifying endoscopic classification is useful in esti-
mating the invasion depth of superficial esophageal squa-
mous cell carcinoma.
Keywords Magnifying endoscopy · Esophageal cancer · 
Squamous cell carcinoma · Invasion depth · Japan 
esophageal society classification
Introduction
Endoscopic resection (ER) can offer patients a curative and 
low-invasive treatment for superficial squamous cell carci-
nomas (SESCCs) [1]. Predicting invasion depth of SESCCs 
is crucial for determining the precise indication for endo-
scopic resection (ER) because the lymph node metastasis 
Abstract Predicting invasion depth of superficial esoph-
ageal squamous cell carcinoma is crucial in determining 
the precise indication for endoscopic resection because 
the rate of lymph node metastasis increases in proportion 
to the invasion depth of the carcinoma. Previous studies 
have shown a close relationship between microvascular 
patterns observed by Narrow Band Imaging magnifying 
endoscopy and invasion depth of the superficial carci-
noma. Thus, the Japan Esophageal Society (JES) devel-
oped a simplified magnifying endoscopic classification for 
estimating invasion depth of superficial esophageal squa-
mous cell carcinomas. We conducted a prospective study 
to evaluate the diagnostic values of type B vessels in the 
pretreatment estimation of invasion depth of superficial 
esophageal squamous cell carcinomas utilizing JES clas-
sification, the criteria of which are based on the degree 
of irregularity in the microvascular morphology. Type A 
microvessels corresponded to noncancerous lesions and 
lack severe irregularity; type B, to cancerous lesions, and 
exhibit severe irregularity. Type B vessels were subclassi-
fied into B1, B2, and B3, diagnostic criteria for T1a-EP or 
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rate increases in proportion to the invasion depth of the 
SESCC [1–3]. According to the Japanese guidelines for 
diagnosis and treatment of esophageal cancer, T1a-EP or 
T1a-LPM SCC is considered an absolute indication for ER; 
T1a-MM or T1b-SM1, a relative indication; and T1b-SM2, 
an investigative stage (functionally speaking, a contraindica-
tion) [4, 5]. Subclassification of invasion depth of SESCC, 
the rate of lymph node metastasis, and the precise indication 
of ER are listed in Table 1 based on previous studies [1–5].
Endoscopic prediction of the depth of invasion is essen-
tial in making decisions regarding the indication for ER in 
SESCCs. Although predicting the invasion depth of SESCC 
is possible by conventional endoscopy, magnifying endos-
copy provides a more accurate prediction of the tumor 
depth, in particular for superficial and flat-type SESCCs [6]. 
Inoue et al. [7–9] and Arima et al. [10–12] proposed magni-
fying endoscopic classifications based upon microvascular 
morphology and reported their diagnostic utility in predict-
ing the histological invasion depth of SESCC as well as in 
deciding precise indications for ER. However, there are con-
cerns that the multiplicity of classifications involving com-
plicated criteria might confuse general endoscopists.
Hence, the committee of the Japan Esophageal Society 
(JES) developed a simplified classification for the magnify-
ing endoscopic diagnosis (characterization and predicting 
invasion depth) of SESCC [13, 14] based on the Inoue and 
Arima classifications [7–12]. Subsequently, we, the com-
mittee members, conducted a prospective multicenter study 




Mainly focused on the abnormal microvessels, this mag-
nifying endoscopic classification offers simplified criteria 
not only for characterization but also for prediction of the 
invasion depth of SESCC [14]. This is essential for develop-
ing a treatment strategy for SESCC, in particular the indica-
tion for ER. Therefore, in this classification, morphological 
types of microvessels are classified into two categories of 
non-cancerous [normal epithelium, inflammation, and low 
grade intraepithelial neoplasia (LGIN)] and cancerous [high 
grade intraepithelial neoplasia (HGIN) and invasive SCC] 
lesions. The cancerous types of microvessels corresponding 
to histology of HGIN or invasive SCC are subclassified into 
three groups based upon an indication for ER as follows: an 
absolute indication type (HGIN, T1a-EP or T1a-LPM), a 
relative indication type (T1a-MM or T1b-SM1), and a con-
traindication type (T1b-SM2).
Diagnostic criteria of the JES classification are based on 
the degree of microvascular irregularity in the target lesion 
observed by magnifying endoscopy. Intrapapillary capil-
lary loops (IPCL) are a basic unit of microvasculature in 
the squamous mucosal surface. The microvascular irregu-
larity is evaluated for the presence or absence of each of the 
following morphological factors: weaving (i.e., tortuosity), 
dilatation, irregular caliber, and different shape (i.e., vari-
ous shapes) [7, 8].
Microvessels are classified as type A if they have three 
or fewer factors and type B if they have all four. Type B is 
then subclassified into B1, B2, and B3 based on the run-
ning pattern or degree of dilatation of severely irregular 
microvessels. The JES classification criteria are summa-
rized in Table 2 and mentioned in detail as follows:
Type A: Normal IPCL (Fig. 1a) or abnormal microves-
sels without severe irregularity (Fig. 1b).
Type B: Abnormal microvessels with severe irregularity 
or highly dilated abnormal vessels.
B1 is defined as type B vessels with a loop-like forma-
tion (Fig. 2a, b). The B1 vessels normally appear as dot-like 
microvessels in a target area (e.g., a brownish area) under 
NBI endoscopic observation with low or no magnification.
B2 is defined as type B vessels without a loop-like 
formation that have a stretched and markedly elongated 
transformation. The B2 vessels often show a multilayered 
Table 1  Relationships among subclassification of invasion depth of SESCC, the rate of lymph node metastasis, and the precise indication of ER
a A contraindication
Tumor depth of superficial esophageal squamous cell carcinoma Lymph node metastasis rate 
(%)
Indication of endoscopic resec-
tion
T1a, Tumor invades 
mucosa (M)
EP Carcinoma in situ (Tis) 0–3.3 Absolute
LPM Tumor invades lamina propria mucosa (LPM)
MM Tumor invades lamina muscularis mucosa (MM) 0–12.2 Relative
T1b, Tumor invades 
submucosa (SM)
SM1 Tumor invades the submucosa to a depth of 
200 µm or less from the muscularis mucosa
8–26.5
SM2 Tumor invades the submucosa to a depth more 
than 200 µm
22–61 % Investigative stagea
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arrangement or an irregularly branched/running pattern 
(Fig. 3a, b).
B3 is defined as highly dilated abnormal vessels whose 
caliber appears to be more than three times that of the usual 
B2 vessels and the B3 vessels often appear green in color 
(Fig. 4a, b) [15].
When target lesions have only type B1 vessels, the histo-
logical invasion depth is predicted as T1a-EP or T1a-LPM. 
When B2 and B3 vessels are seen in target lesions, the his-
tological invasion depth is predicted as T1a-MM or T1b-
SM1 and T1b-SM2 or deeper, respectively.
Auxiliary criteria of the JES classification
Avascular area (AVA)
AVA was originally defined as a low or no vascularity area 
surrounded by stretched irregular vessels such as B2 or B3 
vessels [11, 12]. The definition of AVA does not include the 
stretched irregular vessels in this classification. Thus, AVA 
is surrounded by all subtypes of type B microvessels includ-
ing B1 vessels. [14]. Since a diameter of AVA is positively 
correlated with the histological invasion depth of SESCC, 
the AVA was categorized into three types as follows: AVA-
small (smaller than 0.5 mm in diameter: Fig. 5), AVA-middle 
(0.5 mm or between 0.5 and 3 mm; Fig. 6), and AVA-large 
(3 mm or larger; Fig. 7) [11, 12]. Any types of AVA (small, 
middle, and large) surrounded by B1 vessels are suggestive 
of T1a-EP or T1a-LPM SCC. AVA-middle and AVA-large 
surrounded by B2 or B3 vessels are suggestive of T1a-MM 
or T1b-SM1 and T1b-SM2 invasive SCC, respectively [14].
Reticular pattern (Type R)
Reticular pattern vessels are defined as plexiform microves-
sels (Fig. 6) [11, 12]. This vascular pattern is often found in 
invasive SCC or non-SCC types of malignant epithelial neo-
plasms (e.g., basaloid (-squamous) carcinoma, adenosqua-
mous carcinoma, and endocrine cell carcinoma) with an infil-
trative growth pattern (i.e., INFc) composed of single cells, 
small tumor nests, or a trabecular arrangement of tumor cells.
Intervascular background coloration
Brownish epithelium between microvessels in a brownish 
area visualized by NBI-ME was defined as intervascular 
background coloration [16, 17].
A prospective multicenter study on the predictive value 
of type B vessels for invasion depth of SESCC
From January to August 2011, we prospectively enrolled 211 
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in five high-volume centers (Table 3). Prior to enrollment, 
we used pretreatment imaging (CT and/or MRI) to con-
firm no findings of lymph node metastasis or distant metas-
tasis of SESCC among any of the 211 patients. The depth of 
tumor invasion of the all lesions was estimated prior to treat-
ment using a magnifying endoscope (GIF-H260Z or GIF-
Q240Z; Olympus Corporation, Tokyo, Japan) combined with 
NBI. The estimation of tumor invasion depth by magnifying 
endoscopy was made based upon type B vessels in the JES 
classification and recorded in case report form. The aim of this 
study was to evaluate the diagnostic values of type B vessels 
in the pretreatment estimation of invasion depth of SESCC.
Informed consent was obtained from all participants. The 
informed consent includes information about the possible risks, 
benefits, and limits of the endoscopic procedure and treatment. 
We provided all patients with information about the possibility 
Fig. 1  a Type A vessels of 
normal intrapapillary capil-
lary loops. b Type A vessels of 
abnormal microvessels without 
severe irregularity
Fig. 2  a, b Type B1 vessels 
with a loop-like formation
Fig. 3  a, b Type B2 vessels 
without a loop-like formation 
(white arrows and inside a white 
circle)
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that additional treatments such as surgery or chemoradiother-
apy will be required particularly if ER specimens would show 
SESCC invading the muscularis mucosa or deeper which is 
associated with increased risks of lymph node metastasis and 
distant metastasis. Especially for the patients with pretreatment 
NBI-ME diagnosis of B3 vessels, we provided the patients 
with sufficient explanation as follows: (1) B3 vessels will be a 
suggestive finding of tumor invasion of T1b-SM2 or deeper, (2) 
T1b-SM2 tumor are basically contraindication for ER because 
of considerably high risk of lymph node metastasis and dis-
tant metastasis, (3) additional therapy such as esophagectomy 
and chemoradiotherapy will be required if histology from ER 
would show tumor depth of T1b-SM2 or deeper.
We performed ER on all enrolled patients. The lesions 
were removed by endoscopic mucosal resection or endo-
scopic submucosal dissection. Using the resected speci-
mens, the histological tumor invasion depth was established 
by pathologists in each center with expertise in gastroin-
testinal cancer, according to the Japanese classification of 
esophageal cancer [4]. None of the pathologists were aware 
of any endoscopic findings. We evaluated the diagnostic 
utility of the JES classification in predicting histological 
depth of invasion by comparing the pretreatment NBI-ME 
diagnosis with the histology from resected specimens.
Results
All of the SESCC tumors enrolled in this study had type 
B vessels. The numbers of SESCC tumors subclassified as 
Fig. 4  a, b Type B3 of highly 
dilated abnormal vessels (white 
arrows) whose caliber will be 
more than three times that of 
the B2 vessels around the B3 
vessels
Fig. 5  a Small-sized avascular area (AVA-small). b Middle-sized avascular area (AVA-middle). c Large-sized avascular area (AVA-large). Typi-
cal AVAs are shown by white dotted lines
Fig. 6  Reticular pattern vessels (Type R)
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T1a-EP or T1a-LPM, T1a-MM or T1b-SM1, and T1b-SM2 
were 163, 28, and 20, respectively.
The relationships between histology and pretreatment 
NBI-ME diagnosis of tumor invasion depth are listed in 
Table 4. One hundred fifty-nine (97.5 %) of the 163 T1a-
EP or T1a-LPM tumors were accurately diagnosed by 
pretreatment NBI-ME, and four (2.5 %) were overesti-
mated as T1a-MM or T1b-SM1. Twenty-one of 28 (75 %) 
T1a-MM or T1b-SM1 tumors were accurately diagnosed, 
and seven (25 %) were underestimated as T1a-EP or T1a-
LPM. None of the T1a-EP or T1a-LPM/T1a-MM or T1b-
SM1 tumors were overestimated as T1b-SM2. Eleven of 
20 (55 %) T1b-SM2 tumors were accurately diagnosed. 
Six (30 %) and three (15 %) were underestimated as 
T1a-EP or T1a-LPM and T1a-MM or T1b-SM1, respec-
tively. The overall accuracy of NBI-ME based upon the 
JES classification was 90.5 % (95 % confidence interval, 
85.7–94.1 %).
Table 5 shows the diagnostic values of B1, B2, and B3 
vessels for estimating the depth of invasion of T1a-EP or 
T1a-LPM, T1a-MM or T1b-SM1, and T1b-SM2 tumors, 
respectively. The sensitivity/specificity/positive predictive 
value (PPV) and negative predictive value (NPV) of B1, B2, 
and B3 vessels were 97.5 %/72.9 %/92.4 % and 89.7 %; 
75.0 %/96.2 %/75.0 % and 96.2 %; and 55 %/100 %/100 % 
and 95.5 %, respectively.
Discussion
Endoscopic estimation of invasion depth is a key factor 
in deciding the treatment policy of SESCCs. We, the JES 
committee members, have developed a simplified magnify-
ing endoscopic diagnosis classification (i.e., the JES clas-
sification). We conducted a prospective multicenter study 
focused on evaluating the diagnostic values of type B ves-
sels in the classification for predicting the depth of invasion 
of SESCC.
The overall accuracy rate of the type B1, B2, and B3 
microvessels was 90.5 %, which is of sufficiently high 
accuracy for clinical use. No T1a-EP or T1a-LPM or T1a-
MM or T1b-SM1 tumor was overestimated as T1b-SM2. 
Although 45 % (9/20) of SM2 tumors did not have B3 
vessels, B3 vessels may be highly suggestive of T1b-SM2 
tumors because the PPV of B3 vessels was 100 %.
The sensitivity and PPV of B1 vessels for T1a-EP or 
T1a-LPM tumors were 97.5 and 92.4 %, respectively. Thus, 
B1 vessels will provide optimal decision-making regard-
ing the indication for ER. In contrast, the sensitivity and 
PPV of B2 vessels for T1a-MM or T1b-SM1 tumors were 
both a suboptimal 75.0 %, while the diagnostic accuracy of 
white light endoscopy showed a lower value at 66–74 % 
[18]. Previous studies have indicated that T1a-MM or 
T1b-SM1 tumors without lymphovascular invasion had 
a significantly lower risk of lymph node metastasis and a 
Table 3  Participating high-volume centers
Participated institutions Number of patients
Saku Central Hospital Advanced Care Center 31
Saitama Cancer Center 40
Osaka Medical Center for Cancer and Cardio- 
vascular Diseases
71
Niigata University Medical and Dental Hospital 41
Sendai City Medical Center 28
Table 4  Relationships between 
histology and pretreatment 
ME-NBI diagnosis of depth 
of invasion of superficial 
squamous cell carcinomas
NBI-ME Narrow Band Imaging magnifying endoscopy, EP epithelium, LPM lamina propria mucosae, MM 
muscularis mucosae, SM submucosa, n Number of lesions
NBI-ME diagnosis Histological invasion depth, n
T1a-EP or T1a-LPM T1a-MM or T1b-SM1 T1b-SM2
B1 (T1a-EP or T1a-LPM) 159 7 6
B2 (T1a-MM or T1b-SM1) 4 21 3
B3 (T1b-SM2) 0 0 11
Table 5  Diagnostic values of type B vessels for estimating invasion depth of superficial squamous cell carcinomas
NBI-ME Narrow Band Imaging magnifying endoscopy, EP epithelium, LPM lamina propria mucosae, MM muscularis mucosae, SM submucosa, 
CI confidence interval, PPV positive predictive value, NPV negative predictive value
NBI-ME diagnosis Sensitivity (95 % CI) Specificity (95 % CI) PPV (95 % CI) NPV (95 % CI) Accuracy (95 % CI)
B1 (T1a-EP or T1a-LPM) 97.5 (93.8–99.3) 72.9 (58.2–84.7) 92.4 (87.4–95.9) 89.7 (75.8–97.1) 91.9 (87.4–95.2)
B2 (T1a-MM or T1b-SM1) 75.0 (55.1–89.3) 96.2 (92.3–98.4) 75.0 (55.1–89.3) 96.2 (92.3–98.4) 93.4 (89.1–96.3)
B3 (T1b-SM2) 55.0 (31.5–76.9) 100 (98.1–100) 100 (71.5–100) 95.5 (91.6–97.9) 95.9 (92.1–98.0)
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good prognosis [19–21]. Therefore, T1a-MM or T1b-SM1 
tumors are potential candidates for curative treatment by 
ER. Esophagectomy involves severe problems related to its 
high mortality rate and a decrease in quality of life after 
surgery [22]. Further study on the definition of B2 vessels 
is warranted to reduce the risk of unnecessary surgery for 
patients with T1a-MM or T1b-SM1 tumors.
In the JES classification, we partially modified defini-
tions of AVA, which will be useful to predict invasion depth 
of SESCC as previous studies showed [11, 12]. Although 
AVA was not assessed in this study, we intend to investi-
gate the predictive values of AVA and whether evaluation 
of AVA has a positive effect on the predictive value based 
upon type B vessels (especially for B2 vessels) in an 
upcoming study.
Arima et al. reported that reticular pattern (Type R) ves-
sels were characteristic vascular structure reflecting a histo-
logic infiltrative growth (i.e., INFc) of invasive SCC tumors 
or non-SCC types of malignant epithelial neoplasms. This 
study did not included non-SCC types of malignant epithe-
lial neoplasms and the type R vessels were not seen in inva-
sive SCC tumors included in this study. A validation study 
on type R vessels in predicting the histologic features of 
SCC and non-SCC tumors is warranted.
Intervascular background coloration will be useful for 
predicting histology of HGIN and invasive SCC [16, 17]. 
A recent study indicated that intervascular background col-
oration might be caused by an extravascular component of 
hemoglobin that is produced within tumor cells [23]. The 
other study showed that intervascular background colora-
tion might be related to the thinning of the keratinous layer 
or the epithelium caused by neoplastic cell proliferation 
[17]. In this study, we did not evaluated diagnostic value 
of intervascular background coloration to predict HGIN 
and invasive SCC. The diagnostic validity and reliability of 
intervascular background coloration should be assessed in 
further multicenter studies.
This study had several limitations. First, the number of 
T1a-MM or T1b-SM1 and T1b-SM2 tumors was relatively 
small and no tumor resected by surgery was included. Fur-
ther study including greater or adequate numbers of these 
tumors should be conducted to validate the results of the 
current study. Second, a central review on both the magni-
fying endoscopic findings and the histology was not con-
ducted in this study. The endoscopic diagnosis and histol-
ogy were left to each endoscopist and each pathologist in 
their respective hospitals. Thus, this study may lack diag-
nostic standardization in magnifying endoscopy and histol-
ogy. Third, the endoscopists involved in this study are all 
experts. Additional study involving non-experts is needed 
to determine whether the results of this study on diagnostic 
values are applicable in general. Fourth, the reliability or 
reproducibility of the JES classification was not assessed 
in this study. It would be desirable to investigate inter- or 
intra-observer agreements in future studies.
Conclusions
The newly developed JES classification is proposed to be 
useful in estimating invasion depth of SESCCs. Modifica-
tion of the definition of B2 vessels will be necessary, and 
further studies are required to validate these study results 
as well as to improve the diagnostic utility of the JES 
classification.
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